BusinessLegalPipelineResearchEventsProducts
Browse All Stories »
FEATURED
FDA issues Scope Health warning letter over OPTASE ophthalmic products

FDA issues Scope Health warning letter over OPTASE ophthalmic products

Agency names Allegro, MGD Advanced, and Dry Eye Intense eye drops among products identified as unapproved new drugs and misbranded.

Earn FREE CE 24/7 with Courses by Eyes On Eyecare

Check it out

Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.

TRENDING
Videos
CSI Dry Eye Software releases update for AI-based clinical platform
CSI Dry Eye Software releases update for AI-based clinical platform
Ophthalmology Tech Forum to highlight latest trends and advancements
Ophthalmology Tech Forum to highlight latest trends and advancements
Scope Health brings eyelid health to forefront with new PF OPTASE LIFE eye cream
Scope Health brings eyelid health to forefront with new PF OPTASE LIFE eye cream
Sun Pharma reports positive phase 4 efficacy data on CEQUA after Restasis for DED
Sun Pharma reports positive phase 4 efficacy data on CEQUA after Restasis for DED
Watch More
Business
Barti raises $12M to support expansion of AI-based eyecare EHR
Barti raises $12M to support expansion of AI-based eyecare EHR
Leadership watch: J&J and Rebion appoint new executives
Leadership watch: J&J and Rebion appoint new executives
Opthea to lay off 80% of workforce amid executive cuts
Opthea to lay off 80% of workforce amid executive cuts
Updated reciprocal tariffs to take effect this week
Updated reciprocal tariffs to take effect this week
Research
Are prostaglandins really the most effective glaucoma therapy?
Are prostaglandins really the most effective glaucoma therapy?
Study: IRDs are on the rise in the United States
Study: IRDs are on the rise in the United States
Do seasonal variations impact myopia treatment efficacy?
Do seasonal variations impact myopia treatment efficacy?
New TVC survey reveals tariff and inflation impact on ECPs
New TVC survey reveals tariff and inflation impact on ECPs
Pipeline
FDA extends review period for EYLEA HD expanded labeling
FDA extends review period for EYLEA HD expanded labeling
FDA grants RMAT designation to VeonGen's Stargardt therapy
FDA grants RMAT designation to VeonGen's Stargardt therapy
jCyte doses first patients in RP allogeneic cell therapy trial
jCyte doses first patients in RP allogeneic cell therapy trial
Avista and Forge Biologics partner to advance XLRS gene therapy
Avista and Forge Biologics partner to advance XLRS gene therapy
Products
Coburn releases new HPE-990 lens edger for in-office system use
Coburn releases new HPE-990 lens edger for in-office system use
Iantrek raises $42M for launch of uveoscleral pathway glaucoma tech
Iantrek raises $42M for launch of uveoscleral pathway glaucoma tech
FDA sends warning letters to three eye drop manufacturers
FDA sends warning letters to three eye drop manufacturers
Beyeonics Vision secures US patent for cataract surgical imaging tech
Beyeonics Vision secures US patent for cataract surgical imaging tech
Legal
FDA issues Scope Health warning letter over OPTASE ophthalmic products
FDA issues Scope Health warning letter over OPTASE ophthalmic products
National eyecare organizations launch campaign against NEI consolidation
National eyecare organizations launch campaign against NEI consolidation
Minnesota passes OD scope of practice expansion legislation
Minnesota passes OD scope of practice expansion legislation
FDA scrutiny of unapproved CXL trials reveals critical lapses in patient safety and regulatory adherence
FDA scrutiny of unapproved CXL trials reveals critical lapses in patient safety and regulatory adherence
Archives
Hello 2023 — Weekly Glance
Hello 2023 — Weekly Glance
Can we treat uveitis without steroids? — Weekly Glance
Can we treat uveitis without steroids? — Weekly Glance
Can I have one dilation drop instead of two? — Weekly Glance
Can I have one dilation drop instead of two? — Weekly Glance
Are those dilation reversal drops available yet? — Weekly Glance
Are those dilation reversal drops available yet? — Weekly Glance
Events
Ophthalmology Tech Forum explores next frontier in retina diagnostics and treatment
Ophthalmology Tech Forum explores next frontier in retina diagnostics and treatment
Registration opens for Eyes On Retina 2025
Registration opens for Eyes On Retina 2025
Octane's Ophthalmology Tech Forum highlights AI and personalized medicine
Octane's Ophthalmology Tech Forum highlights AI and personalized medicine
Optometry Divas to host celebratory 10-year anniversary events
Optometry Divas to host celebratory 10-year anniversary events
Browse All Stories »